FGEN
FibroGen, Inc.
Healthcare
$9.50
as of 8 Jan 2026, 18% below its 52-week high
Prices for FGEN have not updated since 8 Jan 2026. The listing may be suspended or delisted, so treat the figures on this page as out of date.
Whether FGEN’s profit and cash have covered its dividend, and how stretched its balance sheet is.
Cover today
- Earnings cover
- Not availableEarnings over dividends paid
- Cash cover
- Not availableFree cash flow over dividends paid
Loading dividend safety
See the Risk signals on the Scores tab
This page shows history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.